arrow
L

Liliana Andrade Chebli

Universidade Federal de Juiz de Fora
H指数:14
被引数:750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and treatment-based risk stratification of opportunistic infections in patients with inflammatory bowel disease: an ambispective cohort study in Brazil

炎症性肠病患者机会性感染的发病率和基于治疗的风险分层:一项巴西前瞻-回顾性队列研究

2026-05-010
PRE
Real-World Comparative Effectiveness and Safety of Ustekinumab Versus Anti-TNF Agents as First- or Second-Line Biologics in Crohn's Disease: A Multicenter Observational Study

真实世界中,乌司木单抗相较于抗-TNF药物的作为克罗恩病的一线或二线生物制剂的疗效与安全性比较:一项多中心观察性研究

2025-12-010
PRE
Reply to the letter on Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?

回复关于巴西免疫介导性炎症疾病中结核感染管理指南的信件:在潜伏性结核筛查中重新检测是否适当和安全?

2025-11-190
OA
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study

维多珠单抗与英夫利昔单抗在未接受过生物治疗的溃疡性结肠炎患者中的临床有效性和安全性: 一项比较真实世界的多中心观察性研究

2025-10-010
OAAI
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety

托法替尼治疗溃疡性结肠炎的巴西研究:一项关于有效性和安全性的多中心观察性研究

2025-03-180
OA
Impact of Obesity on the Course of Inflammatory Bowel Disease
2024-12-010
OA
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial
2023-06-193
OAAI
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey
2021-03-282
OAAI
Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study

宗教和灵性对活动性克罗恩病患者缓解率,精神卫生和生活质量的影响: 一项为期2年的纵向随访研究

2020-06-253
OAAI
Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: Open-label prospective study

硫唑嘌呤治疗皮质类固醇依赖性克罗恩病患者的长期结果: 开放标签前瞻性研究

2007-01-2939
OAAI